Clinical Trial Update: Filgrastim for the Promotion of Collateral Growth in Patients With CAD [NA]

View source ↗

Summary

This document reports the completion of a clinical trial testing filgrastim to promote collateral growth in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Coronary Artery Disease | NA | Status: COMPLETED